$551 Million is the total value of Bellevue Group AG's 130 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | New | Gilead Sciences, Inc. | $21,431,000 | – | 233,300 | +100.0% | 3.89% | – |
| CELG | New | Celgene Corporation | $21,074,000 | – | 210,550 | +100.0% | 3.82% | – |
| MDT | New | Medtronic, Inc. | $20,738,000 | – | 276,500 | +100.0% | 3.76% | – |
| BIIB | New | Biogen Inc. | $19,925,000 | – | 76,540 | +100.0% | 3.62% | – |
| ABT | New | Abbott Laboratories | $15,958,000 | – | 381,500 | +100.0% | 2.90% | – |
| AMGN | New | Amgen Inc. | $15,443,000 | – | 103,000 | +100.0% | 2.80% | – |
| BDX | New | Becton, Dickinson and Company | $15,216,000 | – | 100,225 | +100.0% | 2.76% | – |
| ILMN | New | Illumina, Inc. | $14,853,000 | – | 91,625 | +100.0% | 2.70% | – |
| SYK | New | Stryker Corporation | $13,411,000 | – | 125,000 | +100.0% | 2.43% | – |
| CAH | New | Cardinal Health, Inc. | $13,082,000 | – | 159,630 | +100.0% | 2.37% | – |
| UNH | New | UnitedHealth Group Incorporated | $11,988,000 | – | 93,000 | +100.0% | 2.18% | – |
| REGN | New | Regeneron Pharmaceuticals, Inc. | $11,678,000 | – | 32,400 | +100.0% | 2.12% | – |
| TEVA | New | Teva Pharmaceuticals Industries Ltdadr | $10,450,000 | – | 195,290 | +100.0% | 1.90% | – |
| MYL | New | Mylan Inc. | $10,197,000 | – | 220,000 | +100.0% | 1.85% | – |
| BSX | New | Boston Scientific Corporation | $9,405,000 | – | 500,000 | +100.0% | 1.71% | – |
| ZBH | New | Zimmer Biomet Holdings, Inc. | $9,192,000 | – | 86,200 | +100.0% | 1.67% | – |
| CVS | New | CVS Health Corporation | $8,942,000 | – | 86,200 | +100.0% | 1.62% | – |
| LGND | New | Ligand Pharmaceuticals Incorporated | $8,763,000 | – | 81,830 | +100.0% | 1.59% | – |
| JAZZ | New | Jazz Pharmaceuticals Public Limited Company | $8,159,000 | – | 62,500 | +100.0% | 1.48% | – |
| EARS | New | Auris Medical Holding AG | $7,897,000 | – | 2,169,625 | +100.0% | 1.43% | – |
| ISRG | New | Intuitive Surgical, Inc. | $7,814,000 | – | 13,000 | +100.0% | 1.42% | – |
| ALXN | New | Alexion Pharmaceuticals, Inc. | $6,877,000 | – | 49,400 | +100.0% | 1.25% | – |
| MCK | New | McKesson Corporation | $6,762,000 | – | 43,000 | +100.0% | 1.23% | – |
| SUPN | New | Supernus Pharmaceuticals, Inc. | $6,725,000 | – | 441,000 | +100.0% | 1.22% | – |
| STJ | New | St. Jude Medical, Inc. | $6,710,000 | – | 122,000 | +100.0% | 1.22% | – |
| INCY | New | Incyte Corporation | $6,595,000 | – | 91,000 | +100.0% | 1.20% | – |
| CI | New | Cigna Corporation | $6,588,000 | – | 48,000 | +100.0% | 1.20% | – |
| CNC | New | Centene Corporation | $6,519,000 | – | 105,880 | +100.0% | 1.18% | – |
| EW | New | Edwards Lifesciences Corporation | $6,439,000 | – | 73,000 | +100.0% | 1.17% | – |
| CHRS | New | Coherus BioSciences, Inc | $6,093,000 | – | 287,000 | +100.0% | 1.11% | – |
| SHPG | New | Shire PLCsponsored adr | $5,824,000 | – | 33,880 | +100.0% | 1.06% | – |
| IONS | New | Ionis Pharmaceuticals Inc. | $5,589,000 | – | 138,000 | +100.0% | 1.01% | – |
| HUM | New | Humana, Inc. | $5,489,000 | – | 30,000 | +100.0% | 1.00% | – |
| JNJ | New | Johnson & Johnson | $5,410,000 | – | 50,000 | +100.0% | 0.98% | – |
| MNKKQ | New | Mallinckrodt public limited company | $5,393,000 | – | 88,000 | +100.0% | 0.98% | – |
| BMRN | New | BioMarin Pharmaceutical Inc. | $5,361,000 | – | 65,000 | +100.0% | 0.97% | – |
| BAX | New | Baxter International Inc. | $5,340,000 | – | 130,000 | +100.0% | 0.97% | – |
| VRTX | New | Vertex Pharmaceuticals Incorporated | $5,246,000 | – | 66,000 | +100.0% | 0.95% | – |
| HZNP | New | Horizon Pharma plc | $5,137,000 | – | 310,000 | +100.0% | 0.93% | – |
| BCR | New | C.R. Bard, Inc. | $5,067,000 | – | 25,000 | +100.0% | 0.92% | – |
| AET | New | Aetna Inc. | $5,056,000 | – | 45,000 | +100.0% | 0.92% | – |
| ENDP | New | Endo International PLC | $4,814,000 | – | 171,000 | +100.0% | 0.87% | – |
| HCA | New | HCA Holdings, Inc. | $4,683,000 | – | 60,000 | +100.0% | 0.85% | – |
| INSYQ | New | Insys Therapeutics, Inc. | $4,493,000 | – | 281,000 | +100.0% | 0.82% | – |
| PRGO | New | Perrigo Company plc | $4,171,000 | – | 32,600 | +100.0% | 0.76% | – |
| ANTM | New | Anthem, Inc. | $4,170,000 | – | 30,000 | +100.0% | 0.76% | – |
| ESRX | New | Express Scripts Holding Company | $4,025,000 | – | 58,600 | +100.0% | 0.73% | – |
| XENT | New | Intersect Ent, Inc. | $3,976,000 | – | 209,246 | +100.0% | 0.72% | – |
| BMY | New | Bristol-Myers Squibb Company | $3,833,000 | – | 60,000 | +100.0% | 0.70% | – |
| EGBN | New | Eagle Pharmaceuticals Inc | $3,783,000 | – | 93,400 | +100.0% | 0.69% | – |
| COO | New | Cooper Companies Inc. | $3,618,000 | – | 23,500 | +100.0% | 0.66% | – |
| IPXL | New | Impax Laboratories, Inc. | $3,458,000 | – | 108,000 | +100.0% | 0.63% | – |
| PFE | New | Pfizer Inc. | $3,260,000 | – | 110,000 | +100.0% | 0.59% | – |
| ACHN | New | Achillion Pharmaceuticals, Inc. | $3,242,000 | – | 420,000 | +100.0% | 0.59% | – |
| CYH | New | Community Health Systems, Inc. | $3,236,000 | – | 174,840 | +100.0% | 0.59% | – |
| CERN | New | Cerner Corporation | $3,178,000 | – | 60,000 | +100.0% | 0.58% | – |
| MRK | New | Merck & Co., Inc. | $3,175,000 | – | 60,000 | +100.0% | 0.58% | – |
| ARIA | New | ARIAD Pharmaceuticals, Inc. | $3,163,000 | – | 495,000 | +100.0% | 0.57% | – |
| MASI | New | Masimo Corporation | $3,138,000 | – | 75,000 | +100.0% | 0.57% | – |
| HALO | New | Halozyme Therapeutics, Inc. | $3,011,000 | – | 318,000 | +100.0% | 0.55% | – |
| NVDQ | New | Novadaq Technologies Inc. | $2,994,000 | – | 270,000 | +100.0% | 0.54% | – |
| NKTR | New | Nektar Therapeutics | $2,970,000 | – | 216,000 | +100.0% | 0.54% | – |
| VAR | New | Varian Medical Systems, Inc. | $2,961,000 | – | 37,000 | +100.0% | 0.54% | – |
| ABC | New | AmerisourceBergen Corporation | $2,943,000 | – | 34,000 | +100.0% | 0.53% | – |
| NUVA | New | Nuvasive, Inc. | $2,919,000 | – | 60,000 | +100.0% | 0.53% | – |
| MDVN | New | Medivation, Inc. | $2,897,000 | – | 63,000 | +100.0% | 0.53% | – |
| TMO | New | Thermo Fisher Scientific Inc. | $2,832,000 | – | 20,000 | +100.0% | 0.51% | – |
| HOLX | New | Hologic, Inc. | $2,795,000 | – | 81,000 | +100.0% | 0.51% | – |
| NBIX | New | Neurocrine Biosciences, Inc. | $2,571,000 | – | 65,000 | +100.0% | 0.47% | – |
| LLY | New | Lilly Eli & Co. | $2,520,000 | – | 35,000 | +100.0% | 0.46% | – |
| SGEN | New | Seattle Genetics, Inc. | $2,386,000 | – | 68,000 | +100.0% | 0.43% | – |
| UTHR | New | United Therapeutics Corporation | $2,325,000 | – | 19,300 | +100.0% | 0.42% | – |
| INO | New | Inovio Pharmaceuticals, Inc. | $2,308,000 | – | 265,000 | +100.0% | 0.42% | – |
| ALKS | New | Alkermes Public Limited Company | $2,239,000 | – | 65,500 | +100.0% | 0.41% | – |
| AGIO | New | Agios Pharmaceuticals, Inc. | $2,192,000 | – | 54,000 | +100.0% | 0.40% | – |
| GMED | New | Globus Medical, Inc.cl a | $2,083,000 | – | 87,700 | +100.0% | 0.38% | – |
| QGEN | New | Qiagen NV | $2,044,000 | – | 91,500 | +100.0% | 0.37% | – |
| ZLTQ | New | Zeltiq Aesthetics Inc. | $2,037,000 | – | 75,000 | +100.0% | 0.37% | – |
| LCI | New | Lannett Inc. | $1,933,000 | – | 107,810 | +100.0% | 0.35% | – |
| ANGO | New | AngioDynamics, Inc. | $1,861,000 | – | 151,400 | +100.0% | 0.34% | – |
| HCSG | New | Healthcare Services Group Inc. | $1,841,000 | – | 50,000 | +100.0% | 0.33% | – |
| ICPT | New | Intercept Pharmaceuticals, Inc. | $1,734,000 | – | 13,500 | +100.0% | 0.32% | – |
| NVAX | New | Novavax, Inc. | $1,677,000 | – | 325,000 | +100.0% | 0.30% | – |
| TFX | New | Teleflex Incorporated | $1,572,000 | – | 10,010 | +100.0% | 0.28% | – |
| MGNX | New | Macrogenics, Inc. | $1,556,000 | – | 83,000 | +100.0% | 0.28% | – |
| ALNY | New | Alnylam Pharmaceuticals Inc. | $1,506,000 | – | 24,000 | +100.0% | 0.27% | – |
| DVA | New | Davita Healthcare Partners, Inc. | $1,468,000 | – | 20,000 | +100.0% | 0.27% | – |
| JUNO | New | Juno Therapeutics, Inc. | $1,409,000 | – | 37,000 | +100.0% | 0.26% | – |
| DXCM | New | DexCom, Inc. | $1,358,000 | – | 20,000 | +100.0% | 0.25% | – |
| PRTA | New | Prothena Corporation plc | $1,276,000 | – | 31,000 | +100.0% | 0.23% | – |
| ACAD | New | Acadia Pharmaceuticals, Inc. | $1,258,000 | – | 45,000 | +100.0% | 0.23% | – |
| RDUS | New | Radius Health Inc. | $1,258,000 | – | 40,000 | +100.0% | 0.23% | – |
| BLUE | New | Bluebird Bio, Inc. | $1,233,000 | – | 29,000 | +100.0% | 0.22% | – |
| WMGI | New | Wright Medical Group Inc. | $1,167,000 | – | 70,309 | +100.0% | 0.21% | – |
| LH | New | Laboratory Corporation of America Holdings | $1,171,000 | – | 10,000 | +100.0% | 0.21% | – |
| CLVS | New | Clovis Oncology, Inc. | $1,008,000 | – | 52,500 | +100.0% | 0.18% | – |
| QTNT | New | Quotient Limited | $880,000 | – | 100,000 | +100.0% | 0.16% | – |
| ABBV | New | Abbvie Inc. | $857,000 | – | 15,000 | +100.0% | 0.16% | – |
| INFI | New | Infinity Pharmaceuticals, Inc. | $843,000 | – | 160,000 | +100.0% | 0.15% | – |
| ALDR | New | Alder Biopharmaceuticals Inc. | $808,000 | – | 33,000 | +100.0% | 0.15% | – |
| BIB | New | ProShares Trust | $736,000 | – | 18,000 | +100.0% | 0.13% | – |
| ESPR | New | Esperion Therapeutics Inc. | $676,000 | – | 40,000 | +100.0% | 0.12% | – |
| EXEL | New | Exelixis, Inc. | $680,000 | – | 170,000 | +100.0% | 0.12% | – |
| IBB | New | iSHARES Trustnasdq biotec etf | $652,000 | – | 2,500 | +100.0% | 0.12% | – |
| KITE | New | Kite Pharma, Inc. | $643,000 | – | 14,000 | +100.0% | 0.12% | – |
| RARE | New | Ultragenyx Pharmaceuticals Inc. | $633,000 | – | 10,000 | +100.0% | 0.12% | – |
| TMH | New | Team Health Holdings Inc. | $627,000 | – | 15,000 | +100.0% | 0.11% | – |
| CLDX | New | Celldex Therapeutics, Inc. | $605,000 | – | 160,000 | +100.0% | 0.11% | – |
| LABU | New | Direxion Shares ETF Trustsp biotech bl new | $553,000 | – | 20,175 | +100.0% | 0.10% | – |
| MYGN | New | Myriad Genetics, Inc. | $524,000 | – | 14,000 | +100.0% | 0.10% | – |
| ABUS | New | Arbutus Biopharm Corporation | $516,000 | – | 125,000 | +100.0% | 0.09% | – |
| PODD | New | Insulet Corporation | $497,000 | – | 15,000 | +100.0% | 0.09% | – |
| RMD | New | ResMed Inc. | $463,000 | – | 8,000 | +100.0% | 0.08% | – |
| NVRO | New | Nevro Corp. | $422,000 | – | 7,500 | +100.0% | 0.08% | – |
| PEN | New | Penumbra, Inc. | $368,000 | – | 8,000 | +100.0% | 0.07% | – |
| JNP | New | Juniper Pharmaceuticals Inc. | $331,000 | – | 50,000 | +100.0% | 0.06% | – |
| ECYT | New | Endocyte, Inc. | $310,000 | – | 100,000 | +100.0% | 0.06% | – |
| THC | New | Tenet Healthcare Corporation | $289,000 | – | 10,000 | +100.0% | 0.05% | – |
| IMGN | New | ImmunoGen, Inc. | $256,000 | – | 30,000 | +100.0% | 0.05% | – |
| PTCT | New | PTC Therapeutics Inc. | $225,000 | – | 35,000 | +100.0% | 0.04% | – |
| TBPH | New | Theravance Biopharma, Inc. | $215,000 | – | 11,248 | +100.0% | 0.04% | – |
| XOMA | New | XOMA Corporation | $174,000 | – | 225,000 | +100.0% | 0.03% | – |
| HTWR | New | Heartware International, Inc. | $157,000 | – | 5,000 | +100.0% | 0.03% | – |
| SGRY | New | Surgery Partners, Inc. | $133,000 | – | 10,000 | +100.0% | 0.02% | – |
| ZFGN | New | Zafgen, Inc. | $134,000 | – | 20,000 | +100.0% | 0.02% | – |
| GERN | New | Geron Corporation | $131,000 | – | 45,000 | +100.0% | 0.02% | – |
| TTPH | New | Tetraphase Pharmaceuticals, Inc. | $102,000 | – | 22,000 | +100.0% | 0.02% | – |
| EIGR | New | Eiger BioPharmaceuticals, Inc. | $56,000 | – | 3,333 | +100.0% | 0.01% | – |
| AST | New | Asterias Biotherapeutics, Inc. | $9,000 | – | 1,875 | +100.0% | 0.00% | – |
| BTXWS | New | Biotime Inc.w exp 10/01/2018 | $1,000 | – | 2,294 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bellevue Asset Management AG #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
| Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
| Incyte Corporation | 31 | Q3 2023 | 5.4% |
| INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
| ABBOTT LABS | 31 | Q3 2023 | 4.6% |
| ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
| UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
| ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
| Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.